Navigation Links
Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
Date:10/22/2010

sive treatment with antibiotics that is now common practice in the clinic.  Despite this, Bronchitol produced a clinically relevant reduction in exacerbations in patients completing the study, and together with recent data showed sustained benefit in lung function out beyond 18 months."

Other results from CF302 presented at the NACF conference underlined both the good safety profile of Bronchitol and patient adherence.  Overall adverse events on Bronchitol were similar to those experienced on control with 7% of patients taking Bronchitol withdrawing due to adverse events compared to 4% of patients on control.  There was no increase in the numbers of bacteria present in the lungs.  The most commonly reported adverse event related to treatment was cough occurring in 6% of the Bronchitol group and 3.3% of the control group.

Moira Aitken, M.D., F.R.C.P. (Edin), Professor of Medicine, Division of Pulmonary and CCM, University of Washington, and lead principal investigator of CF302, stated, "We are excited by the results of the Bronchitol Phase III clinical program.  Across both trials, inhaled mannitol was well tolerated and demonstrated an early and sustained improvement in lung function.  This improvement in FEV1 was achieved on top of aggressive use of concomitant medications such as inhaled antibiotics and rhDNase.  These results, coupled with Bronchitol's novel formulation and portable dry powder inhaler administration, suggest that it will have a significant impact on CF patient well-being."

These conclusions were echoed by participants in CF302:

In treating CF, I take a lot of medications.  Some are pills, like different antibiotics, and some are nebulizers or inhalers such as Albuterol, Pulmozyme.  One in particular – tobramycin – I took when I was sick, but after taking Bronchitol I was able to stop that because it made such a huge difference in my pulmonary function test. K.
'/>"/>

SOURCE Pharmaxis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Pharmaxis ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
2. Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
3. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
4. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
5. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
6. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
7. Pharmaxis Establishes Named Patient Program for Bronchitol
8. Pharmaxis Long-Term Safety Study of Bronchitol Completes
9. Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex® Biliary RX Stent
10. Warner Chilcott Announces FDA Approval of New Oral Contraceptive
11. Repligen Announces Conference Call of Second Quarter Fiscal Year 2011 Results Tuesday, November 2nd, 3:00 p.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 4, 2015  Intec Pharma Ltd. (the "Company") (NASDAQ: ... on developing drugs based on its proprietary Accordion Pill ... public offering in the United States ... price to the public of $6.00 per ordinary share, ... shares are being offered by the Company.  In addition, ...
(Date:8/4/2015)... Aug. 4, 2015 Concord Medical Services Holdings Limited ... hospital management solution provider and operator of the largest network ... , today announced it will release its financial results ... on August 17, 2015. Management will hold a ... 8:00 a.m. EDT on August 18, 2015 (8:00 p.m. in ...
(Date:8/4/2015)... , Aug. 4, 2015 BioElectronics ... over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical devices, announced ... of its ActiPatch 7-day trial device has been ... Pain Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More ... survey and submitted an assessment.  ...
Breaking Medicine Technology:Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2
(Date:8/4/2015)... , ... August 04, 2015 , ... ... which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced their collegiate ... successfully identifying previously undiagnosed cardiovascular abnormalities one program at a time. ...
(Date:8/4/2015)... ... ... Bayco Products, Inc. announces a new industrial-grade LED Dual-LightTM headlamp in a new, ... a flip-up face shield. The sleek contours of the new Nightstick NSP-4614B Low-Profile ... headlamp when raising or lowering their face shield or visor. The 4614 will be ...
(Date:8/4/2015)... ... August 04, 2015 , ... Worldwide Power ... Products is expanding its reach in Texas. Effective July 1st of this year, ... Texas generator division. With the North Texas acquisition, Worldwide Power Products (“WPP”) ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... One of ... interviews to discuss his new book, The Pain Antidote , which provides strategies ... of Las Vegas Recovery Center’s Chronic Pain Treatment Program, wrote the book in conjunction ...
(Date:8/4/2015)... Yardley, Penn. (PRWEB) , ... August 04, 2015 , ... ... helping patients better understand certain health conditions, pictures and medical art can be essential. ... health care providers. , Krames Patient Education solutions have been used by physicians ...
Breaking Medicine News(10 mins):Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3Health News:North Texas Acquisition Press Release 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3
... of 50 years of publishing groundbreaking research, the June ... that highlight pivotal research and significant discoveries in the ... is available without charge from HFES., For over half ... to the safety and efficiency of systems, environments, tools, ...
... July 9, 2008 Led by Anna Catriona Phillips ... a hepatitis A vaccine in young healthy adults and also ... adults. , In the first study, participants consisted of ... hepatitis A vaccine during a morning session (10 am to ...
... Zimmer Holdings, Inc.,(NYSE and SWX: ZMH) announced today its ... broadcast live over the Internet on,Thursday, July 24, 2008, ... quarterly results will be made available at 7:00 a.m. ... webcast can be accessed via Zimmer,s Investor Relations,website at ...
... Wash. -- Many coaches inspire better performance by pressuring ... improve the performance of their analyses. In a simple ... that adding pressure early in their protocol squeezes four ... were really happy to see how well it worked," ...
... procedure keeps heart tissue alive, benefits other organs, study ... to CPR alone, adding extracorporeal life support doubles survival ... by researchers at the National Taiwan University Hospital. , ... artery/vein. The patient receives CPR until the start of ...
... connection , , WEDNESDAY, July 9 (HealthDay News) -- Being born ... cautious personality as an adult. , A study published in ... adults who were born at extremely low birth weights were ... counterparts who had been born at normal weights. , ...
Cached Medicine News:Health News:Human Factors Journal celebrates 50 years 2Health News:Pressured proteins: A little pressure in proteomics squeezes 4-hour step into a minute 2Health News:Pressured proteins: A little pressure in proteomics squeezes 4-hour step into a minute 3Health News:ELS Plus CPR Boosts Blood Flow After Cardiac Arrest 2Health News:Do Underweight Newborns Make for Shy Adults? 2
... Manager is the most ... critical care data management ... PDM is an ... to effortlessly manage all ...
... the wall-mounted organizer with a complete set of ... diameters. The Micro Nest makes it easier for ... cleaning task. These small instrument cleaning brushes from ... such as cannulas. ISI Micro Brushes are available ...
... Instra-Glide Target is the non-silicone lubricant ... , ,Instra-Glide Target lubricates sticky pivot points, ... The penetration straw allows you to lubricate ... and painted surfaces. Ideal for carts, hinges, ...
... Hemaway Original attacks dried blood, tissue, ... in hard to reach places such as ... reducing the need for scrubbing. Hemaway Original ... but gentle enough to be used everyday. ...
Medicine Products: